Page last updated: 2024-08-16

ribavirin and Peripheral Nerve Diseases

ribavirin has been researched along with Peripheral Nerve Diseases in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (60.00)29.6817
2010's4 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Donnelly, G; Friedrich, B; Hensley, LE; Keeney, A; Lin, K; Nalca, A; Olinger, G; Reed, C; Shamblin, J; Smith, DR; Wilhelmsen, C1
Ohmichi, T; Oka, N; Yasuda, R; Yoshioka, A; Yuki, N1
Benstead, TJ; Chalk, CH; Parks, NE1
Chrissafidou, A; Musch, E1
Berg, KT; Harrison, AR; Lee, MS; McLoon, LK; Nelson, B1
Bryce, AH; Dispenzieri, A; Gertz, MA; Kyle, RA1
Ahern, M; Cai, FZ; Smith, M1
Battistin, L; Bernardinello, E; Briani, C; Cavalletto, L; Chemello, L; Ermani, M; Gatta, A; Ruggero, S; Toffanin, E; Zara, G1
Manns, MP; Tillmann, H; Trebst, C; Wedemeyer, H; Windhagen, A1
Brindani, F; Gemignani, F; Marbini, A1

Reviews

1 review(s) available for ribavirin and Peripheral Nerve Diseases

ArticleYear
Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection.
    The Cochrane database of systematic reviews, 2014, Dec-20, Issue:12

    Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal, Murine-Derived; Antiviral Agents; Cryoglobulinemia; Cyclophosphamide; Hepacivirus; Hepatitis C; Humans; Immunologic Factors; Interferon-alpha; Peripheral Nervous System Diseases; Randomized Controlled Trials as Topic; Ribavirin; Rituximab

2014

Trials

1 trial(s) available for ribavirin and Peripheral Nerve Diseases

ArticleYear
Peripheral neurotoxicity of pegylated interferon alpha: a prospective study in patients with HCV.
    Neurology, 2006, Sep-12, Volume: 67, Issue:5

    Topics: Adolescent; Adult; Aged; Antibodies; Antiviral Agents; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Gangliosides; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Neural Conduction; Neurologic Examination; Peripheral Nervous System Diseases; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Retrospective Studies; Ribavirin; RNA, Viral; Statistics, Nonparametric; Sulfoglycosphingolipids; Time Factors

2006

Other Studies

8 other study(ies) available for ribavirin and Peripheral Nerve Diseases

ArticleYear
Aerosol exposure to Rift Valley fever virus causes earlier and more severe neuropathology in the murine model, which has important implications for therapeutic development.
    PLoS neglected tropical diseases, 2013, Volume: 7, Issue:4

    Topics: Animals; Antiviral Agents; Disease Models, Animal; Female; Mice; Mice, Inbred BALB C; Peripheral Nervous System Diseases; Ribavirin; Rift Valley Fever; Rift Valley fever virus; Viral Vaccines

2013
Hepatitis C virus-associated neuropathy accompanied by eosinophilic vasculitis and granuloma formation.
    Internal medicine (Tokyo, Japan), 2014, Volume: 53, Issue:11

    Topics: Antiviral Agents; Eosinophilia; Granuloma; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Peripheral Nervous System Diseases; Purpura; Ribavirin; Sural Nerve; Vasculitis; Viral Load

2014
[Peripheral polyneuropathy and bilateral optic neuropathy during treatment of chronic hepatitis C].
    Deutsche medizinische Wochenschrift (1946), 2009, Volume: 134, Issue:18

    Topics: Adrenal Cortex Hormones; Amantadine; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Middle Aged; Optic Nerve Diseases; Papilledema; Peripheral Nervous System Diseases; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome; Vision Disorders

2009
Pegylated interferon alpha-associated optic neuropathy.
    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2010, Volume: 30, Issue:2

    Topics: Antiviral Agents; Atrophy; Blindness; Hepatitis C; Humans; Iatrogenic Disease; Interferon alpha-2; Interferon-alpha; Magnetic Resonance Imaging; Male; Middle Aged; Optic Nerve; Optic Neuropathy, Ischemic; Paresthesia; Peripheral Nerves; Peripheral Nervous System Diseases; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Visual Fields

2010
Natural history and therapy of 66 patients with mixed cryoglobulinemia.
    American journal of hematology, 2006, Volume: 81, Issue:7

    Topics: Adrenal Cortex Hormones; Aged; Antibodies, Monoclonal; Antineoplastic Agents; Antiviral Agents; Cryoglobulinemia; Databases, Factual; Disease-Free Survival; Female; Follow-Up Studies; Hepatitis C; Humans; Interferons; Kidney Diseases; Lymphoproliferative Disorders; Male; Middle Aged; Peripheral Nervous System Diseases; Purpura; Retrospective Studies; Rheumatic Diseases; Ribavirin; Severity of Illness Index

2006
Treatment of cryoglobulinemia associated peripheral neuropathy with rituximab.
    The Journal of rheumatology, 2006, Volume: 33, Issue:6

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Cryoglobulinemia; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Immunologic Factors; Interferon-alpha; Male; Middle Aged; Peripheral Nervous System Diseases; Prednisolone; Remission Induction; Ribavirin; Rituximab

2006
Treatment of hepatitis C virus-associated inflammatory polyneuropathy with pegylated interferon-alpha and ribavirin.
    European journal of gastroenterology & hepatology, 2007, Volume: 19, Issue:1

    Topics: Aged; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Peripheral Nervous System Diseases; Polyethylene Glycols; Recombinant Proteins; Ribavirin

2007
Antiviral therapy for cryoglobulinemic neuropathy: comment on the article by Saadoun et al.
    Arthritis and rheumatism, 2007, Volume: 56, Issue:8

    Topics: Antiviral Agents; Cryoglobulinemia; Drug Carriers; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Peripheral Nervous System Diseases; Polyethylene Glycols; Recombinant Proteins; Remission Induction; Ribavirin

2007